Clinical chemistry

5 February 2019

Dubai World Trade Centre

Overview:

This conference provides learning and understanding of biomarkers as clinical and diagnostic tools and as surrogate endpoints in clinical research with the goal of providing context for interpreting studies that rely heavily on such biological measures. MEDLAB will provide chemistry laboratory professionals latest clinical solutions for better quality and turnaround time and technology usage.

Key topics:

  • Characterisation and evaluation of biomarkers
  • Global overview of HbA1c test performance
  • Laboratory evaluation of vitamin B12 status
  • Updates on lipids
  • Updates on Inflammatory markers
  • Updates on for cardiac markers and Hs-TnT

Benefits of attending

  • Identify latest updates in assays
  • Discuss analytical and clinical applications of high sensitive troponin
  • Appraise use of biomarkers in clinical laboratory
  • Review diagnostic and prognostic biomarkers in inflammatory

08:45

Opening remarks

Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Session 1

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

9:00

Bone markers in osteoporosis

Dr Nandini Rao, Consultant Chemical pathology/metabolic medicine, King's College Hospital, London, UK

09:30

The laboratory evaluation of vitamin B12 status: No easy task

Dr Manal Al Kindi, Senior Consultant, Chemical Pathologist & Clinical Lipidiologist, Program Director-Clinical Biochemistry Program, Oman Medical Specialty Board, Royal Hospital, Muscat, Oman

10:00

Laboratory quality control and patient safety

Dr Jeremie Gras, Clinical Biologist, Clinique Saint-Luc Bouge, Namur, Belgium

10:30 Coffee Break


Session 2

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

11:15

Advances in mass spectrometry – future diagnostic uses, how Mass spectrometry is being automated for common analytes

Prof Patrick Twomey, Consultant Chemical Pathologist, Head of Department/Laboratory Director for Clinical Chemistry, St. Vincent’s University Hospital, Dublin, Ireland

11:45

Strategies to improve test utilisation in clinical chemistry laboratory

Dr Anwar Abdullah Borai, Clinical Scientist, Assistant Professor, Clinical Biochemistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA

12:15 Lunch Break


Session 3

Moderator: Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

13:30

The added value of a challenging EQA programme

Dr Finlay McKenzie, Deputy Director, Wolfson EQA Laboratory, Birmingham, UK

14:00

Sepsis biomarkers: Can they really help?

Dr Ashraf Mahmoud Elhoufi, Board Member, Emirates Intensive Care Society; Consultant Intensivist, Dubai Hospital, Dubai, UAE

14:30

Toward a global overview of HbA1c test performance

Prof Riad Abdel-Latif Bayoumi, Chair, Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University Of Medicine and Health Sciences (MBRU), Dubai, UAE

15:00 Coffee Break


Session 4

Moderator: Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

15:30

Lipids update

Dr Waleed Tamimi, Head, Clinical Chemistry Lab and POCT, King Abdulaziz Medical City,
Ministry of National Guard Health Affairs, Riyadh, KSA

16:00

Serum Protein Electrophoresis: A clinical overview with case studies

Dr Samia Sobki, Consultant and Head of Clinical Chemistry Division, Prince Sultan Military Medical City, Riyadh, KSA

16:30

ABCD of proteinuria, albumin or protein to creatinine ratio

Dr Mrinalini Patwardhan, Biochemist, Medical Officer and Lifestyle Consultant, Satyajit Clinic, Dr Patwardhan’s Pathology Laboratory, Mumbai, India

17:00 End of conference

Chairs:

Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE
Dr Laila Abdel Wareth,
Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Co-Chair:

Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

 


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

 

Dr Anwar Abdullah Borai, Clinical Scientist, Assistant Professor, Clinical Biochemistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA
Dr Ashraf Mahmoud Elhoufi,
Board Member, Emirates Intensive Care Society; Consultant Intensivist, Dubai Hospital, Dubai, UAE
Dr Finlay McKenzie,
Deputy Director, Wolfson EQA Laboratory, Birmingham, UK
Dr Manal Al Kindi,
Senior Consultant, Chemical Pathologist & Clinical Lipidiologist, Program Director-Clinical Biochemistry Program, Oman Medical Specialty Board, Royal Hospital, Muscat, Oman
Dr Mrinalini Patwardhan,
Biochemist, Medical Officer and Lifestyle Consultant, Satyajit Clinic, Dr Patwardhan’s Pathology Laboratory, Mumbai, India
Dr Nandini Rao,
Consultant Chemical pathology/metabolic medicine, King's College Hospital, London, UK
Prof Patrick Twomey,
Consultant Chemical Pathologist, Head of Department/Laboratory Director for Clinical Chemistry, St. Vincent’s University Hospital, Dublin, Ireland
Prof Riad Abdel-Latif Bayoumi, Chair, Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University Of Medicine and Health Sciences (MBRU), Dubai, UAE
Dr Samia Sobki,
Consultant and Head of Clinical Chemistry Division, Prince Sultan Military Medical City, Riyadh, KSA
Dr Waleed Tamimi,
Head, Clinical Chemistry Lab and POCT, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, KSA


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: